Absorbable Interface Screw Clinical Trial
Anterior Cruciate Ligament Rupture
About this trial
This is an interventional treatment trial for Anterior Cruciate Ligament Rupture focused on measuring Anterior cruciate ligament, absorbable interface screws
Eligibility Criteria
Inclusion Criteria:
① Before surgery, subjects or guardians are willing and able to sign the informed consent;
Patients aged 18 to 80 (including 18 and 80 years old), regardless of gender;
Patients who meet the diagnostic criteria for anterior cruciate ligament rupture of the knee joint and have no contraindications to implantation;
The patient's bones are mature;
- Good compliance, willing and able to conduct follow-up observation as required.
Exclusion Criteria:
① Subjects who have participated in other clinical studies of drugs, biological agents or medical devices before being selected and did not reach the primary study endpoint;
The patient is known to have a history of allergy to one or more implanted materials;
Those who are physically weak or cannot tolerate surgery due to other diseases of the body;
- Active infection in the knee joint or other parts of the body; ⑤ Those with other ligament injury and/or meniscus injury in the affected knee joint; ⑥ Those who need to perform simultaneous meniscus repair and other surgeries on the ipsilateral knee joint; ⑦ Obese BMI>35;
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Absorbable screw (Natong Biotechnology (Beijing) Co., Ltd.)
Absorbable screw (Inion Oy, INION, Finland)
Anterior cruciate ligament reconstruction uses absorbable interface screws manufactured by Natong Biotechnology.
Anterior cruciate ligament reconstruction uses absorbable interface screws manufactured by INION.